AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
ABBV vs AMGN Fundamental Comparison
| Metric | ABBV | AMGN |
|---|---|---|
| Revenue | $15.0B | $8.6B |
| Net Income | $695.0M | $1.8B |
| Net Margin | 4.6% | 21.1% |
| ROE | N/A | 19.8% |
| ROA | 0.5% | 2.0% |
| Current Ratio | 0.80x | 1.26x |
| Debt/Equity | N/A | 6.24x |
| EPS | $0.39 | $3.34 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs AMGN: Frequently Asked Questions
Is ABBV or AMGN the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. ABBV is graded C (78% confidence) while AMGN is graded A (79% confidence). This is not investment advice.
How does ABBV compare to AMGN fundamentally?
AbbVie Inc. has ROE of N/A vs AMGEN INC's 19.8%. Net margins are 4.6% vs 21.1% respectively.
Which stock pays higher dividends, ABBV or AMGN?
ABBV has a dividend yield of N/A or no dividend while AMGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or AMGN for long term?
For long-term investing, consider that ABBV has a C grade with 78% confidence, while AMGN has a A grade with 79% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs AMGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs AMGN, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.